Cardiology

Top Story

Virtual visits feasible for patients transitioning to home after HF: ViV-HF

September 16, 2019
In the Journals

Some people without CVD may benefit from aspirin regimen

September 16, 2019
If one CVD event was considered to be equivalent to one major bleed, 2.5% of women and 12.1% of men without CVD were likely to have a 5-year net benefit from an aspirin…
Meeting News

AMBER: Patiromer enables persistent spironolactone treatment in patients with hypertension, CKD

September 16, 2019
PHILADELPHIA — Concomitant use of the potassium binder patiromer enabled more patients with resistant hypertension and advanced chronic kidney disease to continue…
Meeting NewsPerspective

PARAGON HF Echo: RV enlargement among predictors of events in HFpEF

September 16, 2019
PHILADELPHIA — Right ventricular enlargement, left ventricular hypertrophy and elevated left- and right-sided pressures were among the predictors of HF…
Meeting News

DEFINE-HF: Dapagliflozin improves HF-related health regardless of diabetes status

September 16, 2019
PHILADELPHIA — In patients with HF with reduced ejection fraction with or without diabetes, the SGLT2 inhibitor dapagliflozin was associated with clinically…
More Headlines »